Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042)

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042) - EORTC Weber meningioma study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32223

Enrollment

Registered

2008-08-20

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atypical and malignant meningioma

Interventions

High dose radiotherapy (70 Gy)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: summary of protocol page 22: Adult patients in a fair condition after resection of an intracranial atypical or malignant meningioma.

Exclusion criteria

Exclusion criteria: not D4a

Design outcomes

Primary

Measure	Time frame
Disease free survival	—

Secondary

Measure	Time frame
Toxicity	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)